Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ANTHEM Stock Analysis
Views
Red Flags
Positive
High ROE
High operating margin
Strong revenue growth and in line with median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Weak price momentum
Analysts have been downgrading forward EPS estimates
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ANTHEM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ANTHEM Bulk, Block & Insider Trades
ANTHEM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company helps new and established biotech’s and big pharma, develop, optimize and tes... Read More
Key personnel
Mr. Ajay BhardwajD
Chief Executive Officer, Managing Director (Promoter)
Mr. Mohammed Gawir Baig
Chief Financial Officer
Ms. Divya Prasad
Compliance Officer, Company Secretary
Mr. K Ravindra ChandrappaD
Director (Promoter)
Mr. Ganesh SambasivamD
Director (Promoter)
Mr. Satish Chander SubbannaD
Nominee Director
Ms. Shubha KulkarniD
Independent Director
Mr. Subramanian MadhavanD
Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Anthem Biosciences Ltd.?
The current share price of Anthem Biosciences Ltd. is ₹ 629.50 as of 09 Jan 2026.
What is the PE ratio of Anthem Biosciences Ltd.?
The Price-to-Earnings (PE) ratio of Anthem Biosciences Ltd. is 78.34 as of the latest financial data.
What is the ROE and ROCE of Anthem Biosciences Ltd.?
Anthem Biosciences Ltd. has a Return on Equity (ROE) of 18.21% and a Return on Capital Employed (ROCE) of 22.37% as per the latest financial reports.
What is the market cap of Anthem Biosciences Ltd.?
The market capitalization of Anthem Biosciences Ltd. stands at ₹ 35,353.30 Cr.
What is the dividend yield of Anthem Biosciences Ltd.?
The dividend yield of Anthem Biosciences Ltd. is - based on the current market price.
What is the RSI of Anthem Biosciences Ltd.?
The Relative Strength Index (RSI) of Anthem Biosciences Ltd. is 39.77.
What is the FII and DII holding in Anthem Biosciences Ltd.?
Foreign Institutional Investors (FII) hold 1.66% and Domestic Institutional Investors (DII) hold 7.10% of Anthem Biosciences Ltd. shares.
What sector does Anthem Biosciences Ltd. belong to?
Anthem Biosciences Ltd. operates in the Healthcare sector.
What is the beta of Anthem Biosciences Ltd. stock?
The beta of Anthem Biosciences Ltd. stock is -, indicating its volatility relative to the broader market.
